© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Mind Medicine (MindMed) Inc. (MNMD) shows an Average True Range (ATR) of 0.75 and an Enterprise Value of 510.86M. Its average trading volume over the past 3 months is 2M, indicating liquidity. These fundamental metrics provide insight into MNMD's underlying financial health and market activity.
Mind Medicine (MindMed) Inc. (MNMD) technical indicators as of December 23, 2025: the SMA 20 is 7.5%, SMA 50 at 8.44%, and SMA 200 at 46.17%. The RSI 14 value is 61.84, suggesting its current momentum. These technical analysis signals help assess MNMD's price trends and potential future movements.
Mind Medicine (MindMed) Inc. (MNMD) stock performance overview as of December 23, 2025: The 52-week high is $14.43 (currently -7.83% below), and the 52-week low is $4.7 (currently 182.98% above). Over the past year, MNMD's performance is 79.73%, compared to the S&P 500's 10.56% change.
According to market data, Mind Medicine (MindMed) Inc. (MNMD) stock's recent performance metrics show that over the last month, MNMD is 21.68%, with a Year-to-Date (YTD) performance of 91.09%. Over the past year, the stock has seen a 79.73% change. These figures summarize MNMD's price movements across various periods, reflecting its historical returns.
According to current financial data, MNMD stock's P/E (TTM) ratio is -7.20, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for MNMD, including P/S (N/A), P/B (9.27), and P/FCF (-12.63), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.